Drug recall D-0222-2024
Product
buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03
Reason for recall
Presence of Foreign Tablets/Capsules
Lots and codes
Lot #: BPA123098A, Exp. Date 06/2025
Recall details
- Recalling firm
- Rising Pharma Holding, Inc., East Brunswick, NJ
- Quantity
- 47,976 bottles
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- December 29, 2023
Related products
- Bupropion hydrochloride – drug information
- NDC 16571-863 Bupropion hydrochloride · Bupropion Hydrochloride 300 mg/1 · Rising Pharma Holdings, Inc.
- NDC 16571-862 Bupropion hydrochloride · Bupropion Hydrochloride 150 mg/1 · Rising Pharma Holdings, Inc.